Daniel Beltran is a Spanish Molecular Biologist that has dedicated most of his scientific career to unveil the genetic causes of human diseases.
In 1994 he graduated in Molecular Biology by the Autonomous University of Madrid, where he also obtained his PhD degree on the molecular basis of a metabolic disease, Alkaptonuria.
In 2000-2003 he worked as a postdoctoral fellow at University Medical Center Nijmegen (Holland) and discover the genetic basis of a developmental disease, Walker Warburg syndrome.
In 2004 he joined Kevin Campbell’s lab (HHMI) at the University of Iowa where he studied the role of the cell membrane receptor dystroglycan in epithelial derived cancers. He became faculty member and taught human physiology to college students.
In 2015 he joined Invitae, a biotech company based in San Francisco, where he is using his expertise in bringing high quality genetic diagnosis to thousands of patients affected with several genetic pathologies.
Beltran was finalist of the 2002 Student Award of The American Society of Human Genetics. On 2003 he was finalist of the Young Scientist Award of The European Society of Human Genetics. On 2009, Beltran was selected as "Paper of the Week" by Journal of Biological Chemistry.
PhD Molecular Biologist